KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Asset Writedowns and Impairment (2016 - 2026)

NovoCure's Asset Writedowns and Impairment history spans 13 years, with the latest figure at $712000.0 for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 68.51% to $712000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 million, a 2.36% increase, with the full-year FY2025 number at $4.9 million, up 318.55% from a year prior.
  • Asset Writedowns and Impairment hit $712000.0 in Q1 2026 for NovoCure, down from $1.9 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for NVCR hit a ceiling of $2.3 million in Q1 2025 and a floor of $112000.0 in Q3 2023.
  • Historically, Asset Writedowns and Impairment has averaged $480588.2 across 5 years, with a median of $216000.0 in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 73.02% in 2023 and later soared 1065.46% in 2025.
  • Tracing NVCR's Asset Writedowns and Impairment over 5 years: stood at $441000.0 in 2022, then plummeted by 73.02% to $119000.0 in 2023, then soared by 215.13% to $375000.0 in 2024, then soared by 416.27% to $1.9 million in 2025, then plummeted by 63.22% to $712000.0 in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for NVCR at $712000.0 in Q1 2026, $1.9 million in Q4 2025, and $230000.0 in Q3 2025.